Table 3.
Event | Simvastatin-allocated | Placebo-allocated | ||
(n = 10269) | (n = 10267) | |||
Myopathy/rhabdomyolysis* | 7 | (0.1%) | 2 | (0.0%) |
Muscle pain/weakness** | 0 | (0.0%) | 1 | (0.0%) |
Hepatitis | 1 | (0.0%) | 1 | (0.0%) |
GI haemorrhage | 1 | (0.0%) | 0 | (0.0%) |
Renal failure | 0 | (0.0%) | 1 | (0.0%) |
Neurological | 0 | (0.0%) | 2 | (0.0%) |
* Includes 1 patient in each group taking non-study statin in addition to study treatment
** CK <10 × ULN